Medicamen Organ, a company in the Pharmaceuticals industry, reported revenue of ₹7.00 crore and a net loss of ₹4.00 crore for the September 2026 quarter.
Medicamen Organ. (NSE: MEDIORG-SM) closed at ₹22.20 on 20 Nov 2026, down 15.4% over the past year. Its market capitalisation is ₹33 crore.
Incorporated in 1995, Medicamen Organics Ltd develops, manufactures, and distributes a broad range of pharmaceutical dosages including generic dosage
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.